Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1068837 ATLANTA, GA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$50,336
+$4,348 QoQ
Shares Held
19,435
+29.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. AVXL ranks #182 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 505,219 $250,957,432
2 PTGX
Protagonist Therapeutics, Inc
 571,618 $70,068,932
3 TWST
Twist Bioscience Corp
 671,866 $69,121,573
4 SRRK
Scholar Rock Holding Corp
 890,607 $48,983,385
5 KRYS
Krystal Biotech, Inc.
 124,442 $46,251,357
6 TGTX
Tg Therapeutics, Inc.
 819,253 $45,009,759
7 PTCT
Ptc Therapeutics, Inc.
 539,319 $43,992,249
8 PRAX
Praxis Precision Medicines, Inc.
 122,227 $40,920,376

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,336 19,435
2026-03-31 $45,988 14,980
2025-12-31 $55,660 15,635
2025-09-30 $139,151 15,635
2025-06-30 $212,797 23,080
2025-03-31 $178,266 20,777
2024-12-31 $244,603 22,775
2024-09-30 $142,454 25,080
2024-06-30 $105,542 25,010
2024-03-31 $125,778 24,711
2023-12-31 $266,033 28,575
2023-09-30 $182,954 27,932
2023-06-30 $227,087 27,932
2023-03-31 $226,102 26,383
2022-12-31 $244,306 26,383
2022-09-30 $272,272 26,383
2022-06-30 $264,093 26,383
2022-03-31 $324,774 26,383
2021-12-31 $434,939 25,083
2021-09-30 $438,715 24,441
2021-06-30 $558,721 24,441
2021-03-31 $380,582 25,457
2020-12-31 $131,139 24,285
2020-09-30 $84,488 18,569
2020-06-30 $91,359 18,569
2020-03-31 $82,413 26,163